Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference18 articles.
1. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;CH Polman;New Engl J Med,2006
2. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study;E Havrdova;Lancet Neurol,2009
3. Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results;H Butzkueven;J Neurol Neurosurg Psychiatry,2014
4. Reader's guide to critical appraisal of cohort studies: 1. Role and design;PA Rochon;BMJ,2005
5. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding;M Mamdani;BMJ,2005
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-10
2. Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab;Journal of Personalized Medicine;2021-12-10
3. Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry;Journal of Neurology;2021-04-22
4. New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab;Frontiers in Neurology;2020-12-17
5. Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP);Journal of Neurology, Neurosurgery & Psychiatry;2020-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3